Linked Life Data

10400906

Source:http://linkedlifedata.com/resource/pubmed/id/10400906

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10400906rdf:typepubmed:Citationlld:pubmed
pubmed-article:10400906lifeskim:mentionsumls-concept:C0026844lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1135918lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C0282625lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C0032200lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1150423lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C1554184lld:lifeskim
pubmed-article:10400906lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:10400906pubmed:issue1lld:pubmed
pubmed-article:10400906pubmed:dateCreated1999-7-30lld:pubmed
pubmed-article:10400906pubmed:abstractTextPP1 has previously been described as an inhibitor of the Src-family kinases p56(Lck) and FynT. We have therefore decided to use PP1 to determine the functional role of Src in platelet-derived growth factor (PDGF)-induced proliferation and migration of human coronary artery smooth muscle cells (HCASMCs). A synthetic protocol for PP1/AGL1872 has been developed, and the inhibitory activity of PP1/AGL1872 against Src was examined. PP1/AGL1872 potently inhibited recombinant p60(c-src) in vitro and Src-dependent tyrosine phosphorylation in p60(c-srcF572)-transformed NIH3T3 cells. PP1/AGL1872 also potently inhibited PDGF-stimulated migration of HCASMCs, as determined in the modified Boyden chamber, as well as PDGF-stimulated proliferation of HCASMCs. Surprisingly, in addition to inhibition of Src kinase, PP1/AGL1872 was found to inhibit PDGF receptor kinase in cell-free assays and in various types of intact cells, including HCASMCs. PP1/AGL1872 did not inhibit phosphorylation of the vascular endothelial growth factor receptor KDR (VEGF receptor-2; kinase-insert domain containing receptor) in cell-free assays as well as in intact human coronary artery endothelial cells. In line with the insensitivity of KDR, PP1/AGL1872 had only a weak effect on vascular endothelial growth factor-stimulated migration of human coronary artery endothelial cells. On treatment of cells expressing different receptor tyrosine kinases, the activities of the epidermal growth factor receptor, fibroblast growth factor receptor-1, and insulin-like growth factor-1 receptor were resistant to PP1/AGL1872, whereas PDGF alpha-receptor was susceptible, albeit to a lesser extent than PDGF beta-receptor. These data suggest that the previously described tyrosine kinase inhibitor PP1/AGL1872 is not selective for the Src family of tyrosine kinases. It is also a potent inhibitor of the PDGF beta-receptor kinase but is not a ubiquitous tyrosine kinase inhibitor. PP1/AGL1872 inhibits migration and proliferation of HCASMCs probably by interference with 2 distinct tyrosine phosphorylation events, creating a novel and potent inhibitory principle with possible relevance for the treatment of pathological HCASMC activity, such as vascular remodeling and restenosis.lld:pubmed
pubmed-article:10400906pubmed:languageenglld:pubmed
pubmed-article:10400906pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:citationSubsetIMlld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10400906pubmed:statusMEDLINElld:pubmed
pubmed-article:10400906pubmed:monthJullld:pubmed
pubmed-article:10400906pubmed:issn1524-4571lld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:LevitzkiAAlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:MazaCClld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:FrankHHlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:BöhmerF DFDlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:GazitAAlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:FujitaDDlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:HombachVVlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:KrollJJlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:WaltenbergerJ...lld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:BjorgeJ DJDlld:pubmed
pubmed-article:10400906pubmed:authorpubmed-author:UeckerAAlld:pubmed
pubmed-article:10400906pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10400906pubmed:day9lld:pubmed
pubmed-article:10400906pubmed:volume85lld:pubmed
pubmed-article:10400906pubmed:ownerNLMlld:pubmed
pubmed-article:10400906pubmed:authorsCompleteYlld:pubmed
pubmed-article:10400906pubmed:pagination12-22lld:pubmed
pubmed-article:10400906pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:meshHeadingpubmed-meshheading:10400906...lld:pubmed
pubmed-article:10400906pubmed:year1999lld:pubmed
pubmed-article:10400906pubmed:articleTitleA dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.lld:pubmed
pubmed-article:10400906pubmed:affiliationDepartment of Internal Medicine, Ulm University Medical Center, Ulm, Germany. johannes.waltenberger@medizin.uni-ulm.delld:pubmed
pubmed-article:10400906pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10400906pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10400906lld:pubmed